Royalty Pharma plc
RPRX
$60.85
-$1.07-1.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 836.99M | 608.30M | 637.50M | 955.04M | 645.11M |
| Total Receivables | 920.93M | 807.36M | 883.70M | 888.97M | 870.68M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.66M | 10.16M | 6.89M | 5.52M | 4.45M |
| Total Current Assets | 1.76B | 1.43B | 1.53B | 1.85B | 1.52B |
|
|
|||||
| Total Current Assets | 1.76B | 1.43B | 1.53B | 1.85B | 1.52B |
| Net Property, Plant & Equipment | -- | 18.30M | 19.10M | 19.80M | 20.60M |
| Long-term Investments | 923.54M | 924.63M | 924.63M | 924.63M | 924.63M |
| Goodwill | 923.54M | 924.63M | 924.63M | 924.63M | 924.63M |
| Total Other Intangibles | -- | -- | -- | 5.32M | 5.32M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.26B | 16.60B | 16.27B | 15.83B | 15.19B |
| Total Assets | 19.82B | 19.82B | 19.62B | 19.35B | 18.32B |
|
|
|||||
| Total Accounts Payable | 35.57M | 25.48M | 19.40M | 41.42M | 20.21M |
| Total Accrued Expenses | 107.77M | 25.30M | 110.82M | 29.04M | 85.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 380.00M | 383.19M | 383.16M | 383.12M | 1.00B |
| Total Finance Division Other Current Liabilities | 107.60M | 101.71M | 122.83M | 77.22M | 98.20M |
| Total Other Current Liabilities | 107.60M | 101.71M | 122.83M | 77.22M | 98.20M |
| Total Current Liabilities | 630.93M | 535.68M | 636.21M | 530.80M | 1.21B |
|
|
|||||
| Total Current Liabilities | 630.93M | 535.68M | 636.21M | 530.80M | 1.21B |
| Long-Term Debt | 8.58B | 8.58B | 8.57B | 8.57B | 7.00B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 15.30M | 16.10M | 16.90M | 17.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 821.24M | 751.16M | 682.61M | 612.98M | 592.77M |
| Total Liabilities | 10.03B | 9.88B | 9.91B | 9.73B | 8.82B |
|
|
|||||
| Common Stock & APIC | 4.38B | 4.38B | 4.12B | 4.11B | 4.13B |
| Retained Earnings | 2.46B | 2.51B | 2.36B | 2.30B | 2.22B |
| Treasury Stock & Other | -2.72M | -2.71M | -2.61M | -2.61M | -2.61M |
| Total Common Equity | 6.83B | 6.89B | 6.48B | 6.41B | 6.35B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.83B | 6.89B | 6.48B | 6.41B | 6.35B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.95B | 3.05B | 3.24B | 3.21B | 3.16B |
| Total Equity | 9.79B | 9.94B | 9.71B | 9.62B | 9.50B |
|
|
|||||